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Abstract 
 In recent years, the consumption of dietary supplements (DS) has increased worldwide. In Argentina, 
approximately 14 million DS units were sold between 2015 and 2017. The adulteration of DS with active 
pharmaceutical ingredients or their analogues has been reported. This represents an alarming emerging risk to 
public health. The aim of this work was to detect the possible adulteration of a DS marketed in Argentina for the 
treatment of erectile dysfunction. Initially, thin layer chromatography analysis of the DS capsules content 
suggested the presence of a major compound. For the isolation and purification of this compound, an easy 
method consisted of a liquid-liquid extraction (water/CH2Cl2) followed by re-crystallisation from ethanol, is 
reported. Spectroscopic techniques such as mono- and bidimensional nuclear magnetic resonance, Fourier 
transform infrared spectroscopy and mass spectrometry allowed its identification as tadalafil. A rapid and                
reliable method was developed for the quantification of tadalafil in this DS by high performance liquid 
chromatography-mass spectrometry (HPLC-MS/MS). The mean content of tadalafil per capsule was 21.2 mg which 
represents a slightly higher value than that found in approved products in Argentina (5 or 20 mg per tablet). In 
addition, an undeclared alga was identified in the DS by microscopic techniques. 
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Introduction 
 Since 1998, the use of dietary supplements (DS) 
in Argentina has been regulated in the “Código 
Alimentario Argentino” (CAA) (Law no. 18284). DS are 
defined as “products used to increase the regular dietary 
intake, supplementing the incorporation of nutrients in 
the diet of healthy people who, in the absence of 
pathological conditions, present an unmet dietary need”. 
In terms of composition, DS should provide nutrients 
such as proteins, vitamins, minerals, lipids,    
carbohydrates, and fibres. Some botanicals or extracts 
thereof can also be used [1]. Initially, DS were mainly 
products based on vitamins, minerals, proteins and fibre, 
but over the last years, and mainly in response to 
consumer demands, the profile of these products has 
changed, and other constituents such as herbal products 
have been incorporated. In 2001, ANMAT, the food and 
drug regulatory agency of Argentina, authorised a total 
of 35 herbs that can be incorporated in DS (ANMAT Res. 
no. 1637/2001). These herbs are Astragalus   
membranaceus, Ginkgo biloba, Panax ginseng, Passiflora 
incarnata, Valeriana officinalis, and Equisetum arvense, 
among others. These herbs are only permitted if 
accompanied by vitamins, minerals, carbohydrates, 
proteins and fibres. The use of DS has increased 
worldwide as a result of the demand for sexual 
enhancement, sports performance enhancement and 
weight loss products. As reported by Harris [2] more 
than 60 % of people do not disclose the use of DS to 
their physicians. People obtain information on DS from 
friends and family, magazines, food stores and the 
Internet and, they often take them without obtaining 
adequate information about the products. An important 
problem arises from the adulteration of these DS with 
either synthetic drugs or drug analogues [3, 4], which 
represents an alarming emerging risk to public health. A 
wide array of DS adulterants has been reported. These 
substances are added to enhance the properties of the 
product [5, 6].  
 In Argentina, approximately 14 million DS units 
were sold between 2015 and 2017 according to IMS [7] 
and only one adulteration has been reported [8]. 
According to Vaclavik et al. [9], the products most 
frequently adulterated with synthetic drugs are those for 
the treatment of erectile dysfunction (ED), obesity/
overweight, diabetes mellitus, hypertension and arthritis.  
 ED is a widespread health problem defined as 
the inability to get or maintain an erection during sexual 
intercourse. It affects ca.150 million men worldwide and 
this number is expected to increase to about 322 million 
by 2025 [10].  Tadalafil, sildenafil and vardenafil are 
selective inhibitors of the type 5 cGMP-specific 
phosphodiesterase (PDE-5) approved for the treatment 
of this condition. These drugs enhance the relaxation   
of the cavernosal smooth muscle, thus enhancing 
erection [8]. Even though PDE-5 inhibitors have a good 
safety profile, they are contraindicated in men taking 
nitrates and they should be administered carefully in 
subjects under multiple antihypertensive medications, as 
they can cause a dramatic decrease of the blood 
pressure [11]. 
 Given that the adulteration of DS is a major 
problem, we have been screening for the detection of 
illegal substances in order to discover products that may 
pose a health risk [8]. In this article we report the 
isolation and the identification, by spectroscopic 
techniques, of tadalafil as an adulterant in a DS 
marketed in Argentina for the treatment of ED.  A rapid 
and reliable method was developed for the quantification 
of tadalafil in this DS by high performance liquid 
chromatography-mass spectrometry (HPLC-MS/MS). An 
undeclared alga was also identified in the DS by 
microscopic techniques.  
Material and Methods 
Chemical and Reagents 
 Analytical grade solvents were purchased from 
Sintorgan (Buenos Aires, Argentina). LiChrosolv® 
methanol (MeOH) and dichloromethane (CH2Cl2) were 
supplied by Merck (Darmstadt, Germany). Formic acid 
was purchased from Baker (New Jersey, USA). Ultrapure 
water was generated in-house with a Barnstead Thermo 
Scientific™ purification system (resistance ≥18.2Ω). 
Analytical thin layer chromatography (TLC) was 
performed on silicagel 60-coated F254 aluminium plates 
(Merck KGaA, Germany). Tadalafil working standard was 
isolated from tablets of CialisTM (20 mg) and its identity 
and purity was evaluated by nuclear magnetic resonance 
(NMR), Fourier transform infrared spectroscopy (FT-IR) 
and mass spectroscopy (MS) and compared to those 
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obtained from tadalafil pharmaceutical secondary 
standard from Sigma Aldrich. Dimethylsulfoxide-d6 
(DMSO-d6, 99.8%) (Sigma, St. Louis, MO, USA) was 
used as solvent in nuclear magnetic resonance (NMR) 
experiments.  
Instrumentation  
  Fourier transform infrared spectroscopy (FT-IR) 
experiments were performed on an Alpha FT-IR 
Spectrometer (Bruker, Madison WI, USA). FT-IR data 
were processed with a Bruker OPUS/IR 7.5.18 software 
and recorded over a spectral range spanning from 4,000 
to 400 cm−1 with an optical resolution of 4 cm−1. NMR 
spectra were recorded on a Bruker Avance III 600 MHz 
equipped with a cryoprobe. Mono- and bidimensional 
NMR experiments were run using the programs from the 
Bruker software. Chemical shift values (δ) were 
expressed in parts per million (ppm). The HPLC-MS/MS 
system consisted of an UltiMate 3000 HPLC device 
coupled to a TSQ Quantum Access MAX Triple 
Quadrupole Mass Spectrometer with electrospray 
ionization (Massachusetts, USA). A Thermo Scientific™ 
Acclaim™ Mixed-Mode HILIC-1 (150 x 4 mm, 5 µm 
particle size) column was used. Microscopic analysis was 
performed in a Zeiss Axioscop 2 plus microscope 
equipped with a Moticam X Wifi camera. 
Thin Layer Chromatography (TLC) Analysis  
 DS samples were obtained in the local market. 
The powder contained in 3 DS capsules was extracted 
with CH2Cl2 (3 x 50 mL) with ultrasonic shaking at 25°C 
for 1 h. The extract was filtered, and the solvent 
evaporated under vacuum at 40°C yielding the dried 
extract. The marc was then extracted with MeOH in the 
same way. Both extracts were analysed by TLC on 
silicagel 60 F254 using ethylacetate: water: n-butanol 
(25:50:100, v/v/v) (upper layer) (system I) and 
chloroform: MeOH: diethylamine (9:1:0.1, v/v/v) (lower 
layer) (system II) as mobile phases. The detection of 
spots was done with UV light (254 and 366 nm) and by 
derivatisation with Draggendorff and anisaldehyde/
sulfuric acid reagents.  
Isolation of a Major Component of the CH2Cl2 Extract 
 To isolate the major compound present in the 
CH2Cl2 extract, the powder contained in 4 capsules (1.42 
g) was extracted with water (100 mL), with ultrasonic 
shaking at 25°C for 15 min. The filtrate was alkalinised 
with 0.1N NaOH to pH=10 and extracted with CH2Cl2            
(3 x 100 mL). The organic phase was evaporated to 
dryness under vacuum at 40°C. This extract was 
dissolved in ethanol at room temperature. The insoluble 
material was collected and re-crystallised from ethanol 
to yield the target compound.   
Identification of the Target Compound by Spectroscopic 
Techniques 
 The structure of the isolated compound was 
determined by 1D (1H- and 13C-) and 2D NMR 
experiments: distortionless enhancement by polarization 
transfer (DEPT 135) and heteronuclear single quantum 
coherence (HSQC), FT-IR and mass spectrometry (MS). 
FT-IR experiments were performed on solid state using 
KBr pellets. The crystals obtained from the compound 
were dissolved in dimethylsulfoxide-d6 (DMSO-d6) for 
NMR experiments.  
HPLC-MS/MS Quantification of the Target Compound  
 Quantification of tadalafil in capsules was carried 
out by a HPLC-MS/MS method previously validated 
according to ICH guidelines [12]. A high-efficiency,  
silica-based, mixed-mode stationary phase HPLC 
column, consisting of a hydrophobic alkyl chain with a 
diol group at the terminus, was used. A mixture of 0.1% 
formic acid in MeOH and 0.1% formic acid in water 
(95:5 v/v) was used as mobile phase for the isocratic 
elution. The flow rate was 0.5 mL/min. Temperatures of 
the oven and the sampler were set at 25°C and 10°C, 
respectively. The injection volume was 5 µL. MS/MS 
optimization conditions were made with a working 
standard solution of tadalafil. Tuning conditions were as 
follows: spray voltage, 3.0 kV; vaporizer temperature, 
193°C; capillary temperature, 266°C; sheath gas 
pressure and aux gas pressure were set at 10 and 5 
units, respectively. Three scan events were performed: 
single ion monitoring (SIM), selective reaction 
monitoring (SRM) and data dependent experiments 
(table 1). 
 A calibration curve (seven concentration levels) 
was prepared from a 1.45 mg/mL stock solution of 
tadalafil working standard in methanolic 0.1% formic 
acid. The final concentrations ranged from 0.001 µg/mL 
to 1.5 µg/mL. Each level was analysed by triplicate.  
 DS samples were prepared as follows: thirty-two 
capsules were emptied, and their content weighed. The 
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average powder content per capsule was determined. 
The content of the capsules was then pooled and 
homogenised (sample powder). Samples were prepared 
in sextuplicate. An amount of 400±20 mg of sample 
powder was accurately weighed and transferred to a   
25 ml volumetric flask. Around 15 ml of HPLC quality 
MeOH were added to each sample followed by 
sonication for 30 min at 25ºC. After allowing samples to 
reach room temperature, sufficient HPLC MeOH was 
added to make a final volume of 25 ml. Samples were 
then filtered through nylon membranes and the filtrates 
diluted. Two 1/100 serial dilutions in methanolic 0.1% 
formic acid were made to yield the sample solutions that 
were injected in duplicate. The content of tadalafil per 
capsule was calculated by extrapolating values from the 
calibration curve and referring it to the average capsule 
content. Results were expressed as mean value ± 
standard deviation. 
Microscopic Analysis of the Capsule Content  
 The capsule content (dried powder) was 
analysed by light microscopy at 100X, 200X, 400X and 
1000X magnification. Images were captured with a   
built-in camera. 
Results and Discussion  
 Among the many reasons why DS are popular 
worldwide include their accessibility, since they are 
readily acquirable in pharmacies as over-the-counter 
products, in supermarkets, through internet websites, in 
natural food stores, in herbal shops and at gyms. People 
believe that these products are 100 % natural, and 
therefore, innocuous and safer than pharmaceutical 
drugs [10].  
 Adulteration of DS by the addition of synthetic 
drugs represents a great problem and a major area of 
concern globally [13]. Synthetic compounds are 
increasingly being detected in DS, turning the detection 
of these adulterants into an important field of active 
research. In this context, we have previously described 
the identification of aminotadalafil, a non-approved 
tadalafil analogue, as an adulterant in a DS marketed in 
Argentina for the treatment of ED [8]. To the best of our 
knowledge, this was the first report of an adulteration of 
a DS in Argentina. In this study we report the presence 
of tadalafil as an adulterant in another DS also employed 
for ED and marketed in our country and labeled to 
contain only herbs and vitamins.  
Thin Layer Chromatography (TLC) Analysis   
 As a first approach, a TLC analysis of CH2Cl2 and 
MeOH extracts of the capsule content was carried out to 
analyse the presence of the herbal drugs declared on 
the label. The TLC analysis of plant extracts normally 
renders chromatograms with numerous spots 
corresponding to a wide variety of plant metabolites. 
Many sources including pharmacopeias such as the US 
Pharmacopeia-National Formulary and the European 
Pharmacopoeia, and reference bibliography [14] detail 
the TLC techniques that can be used to analyse and 
identify different plant drugs. Normally, when herbal 
products containing many plant organs are analysed by 
TLC after an extraction procedure, complex   
chromatograms are obtained, especially those obtained 
with methanolic extracts. The TLC chromatograms 
obtained with the CH2Cl2 and MeOH extracts of the DS 
showed a small number of spots blurred by a greenish 
colour. The simplicity of the chromatograms was 
suspicious, together with the finding that the CH2Cl2 
extract presented a major compound. However, the 
purification of such compound was not easy due to 
sample matrix complexity, which is known to affect the 
performance of analytical methods, e.g. co-extraction 
phenomena may occur [13]. Knowing that the majority 
of the adulterated DS used as sexual enhancers contain 
approved synthetic PDE-5 inhibitors or their analogues 
and considering that most of those inhibitors contain 
Compound Parent ion (m/z) Product ion (m/z) CE (eV) 
    240.0 59 
Tadalafil 390.2     
    268.0 13 
Table 1. SIM and SRM parameters for tadalafil 
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nitrogen atoms in their structure [13, 15, 16] we 
developed a rapid and easy purification method.  
Isolation an Identification of the Major Component of 
the CH2Cl2 Extract 
 The isolation consisted of a liquid-liquid 
extraction (water/CH2Cl2) profiting from the acid-base 
properties of such compounds, followed by                  
re-crystallisation from ethanol, to afford the target 
compound as white crystals. In our previous work, the 
isolation of the adulterant was accomplished by a single 
column chromatography process that yielded the pure 
compound. In this case, the sample matrix seemed less 
complex as shown by the TLC and HPLC profiles [8]. 
Spectroscopic data (Figures 1 and 2) allowed                          
the identification of the major compound as tadalafil 
(Figure 3) [17, 18]. 
HPLC-MS/MS Quantification of Tadalafil in the DS 
Capsules 
 For the quantification of tadalafil in the DS, the 
HPLC chromatographic conditions needed optimisation. 
Several methods using liquid chromatography have been 
previously described for the identification of tadalafil and 
related compounds [19, 20, 21]. Given the chemical 
characteristics of tadalafil, several additives, such as 
triethanolamine, trifluoroacetic acid and formic acid have 
been used to avoid tailing. As shown in figure 3, the 
tadalafil molecule presents several nitrogen atoms, 
which interact with the stationary phase resulting in an 
irregular peak shape. This has been partially improved 
by the addition of mobile phase modifiers. In our 
method, we replaced the typical reverse phase by one 
that combines both reverse-phase and hydrophilic 
interactions. The Acclaim® Mixed-Mode HILIC-1 column 
provided by Thermo Scientific was employed. The 
particular properties of this stationary phase are given 
by the covalent functionalisation of high-purity spherical 
silica with a silyl ligand consisting of both an alkyl chain 
and a diol group. The use of this stationary phase not 
only avoids peak tailing, thus providing an improved 
symmetry and sensitivity, but also prevents ionic 
suppression given by the addition of mobile phase 
Figure 1. 1H- and 13C- NMR spectra of 
tadalafil 
Figure 2. DEPT 135 and HSQC NMR spectra of 
tadalafil 
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additives and the detriment of the column performance.   
 For the optimisation of MS/MS conditions, a 
standard solution of 1.0 µg/mL tadalafil was first infused 
directly into the spectrometer at a flow rate on 10 µL/
min. In a full scan spectrum, the main peak of the 
standard corresponded to a m/z=390.4, representing 
the [M+H]+. Therefore, this was chosen as the precursor 
ion. Secondly, the most abundant product ions were 
determined, and their collision energies optimised. 
These product ions correspond to m/z=268.0 and m/
z=240.0 (Table 1). Once the tuning conditions were 
optimised, the method settings were established. Three 
scan events were set, which comprised a full scan, a 
single ion monitoring (SIM) and a data dependent 
experiment. While the SRM experiment was used for the 
quantification of tadalafil, the data dependant 
experiment was employed for the identification of 
tadalafil by comparing the full spectrum of the peak with 
that of the standard. Chromatograms and spectra 
obtained from the standard and sample are shown in 
figure 4. 
 The content of tadalafil in the DS was 
determined by HPLC-MS/MS. The mean content per 
capsule was 21.2 ± 2.6 mg which represents a slightly 
higher value than that found in approved products in 
Argentina, i.e., 5 or 20 mg per tablet [22]. Taking these 
results into account, it can be concluded that, unlike 
pharmaceuticals, certain DS are not subjected to a 
complete quality control process. This entails a 
substantial variability in the tadalafil content among 
capsules. Even though the amount of tadalafil found is 
similar to that found in approved marketed products, the 
presence of this drug in DS poses a serious health risk. 
As stated above, most patients consuming DS are 
unaware of potential adulterations and many consider 
DS as safe natural products. The common side effects 
Figure 4. HPLC chromatograms corresponding to tadalafil standard (a y b) and sample solutions (c y 
d) in SIM and SRM mode respectively. 
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associated with PDE-5 inhibitors include flushing, 
headache, dyspepsia, back pain, myalgia, dizziness, and 
rhinitis, but these effects are self-limited. However, 
some other more serious drug-related problems may 
occur, such as visual and auditory changes,  
cardiovascular effects, and alterations of renal and 
hepatic functions [11]. Adulteration with synthetic drugs 
and their analogues pose a pharmacological and 
toxicological health risk but also the presence of 
impurities and degradation products may be of 
relevance [23].  
Microscopic Analysis of the Capsule Content 
 Microscopic methods are used as part of the 
identification tests when the DS contains either intact 
plant material or its powder [4].  Microscopic methods 
can detect other herbal drugs as adulterants as well as 
the presence of undeclared plant parts. In order to 
verify the presence of the herbal drugs declared in the 
DS label, we analysed the capsules content by light 
microscopy and polarized light microscopy. The analysis 
showed mainly the presence of the alga Arthrospira sp. 
and numerous simple starch grains (Figure 5). The 
presence of Arthrospira was confirmed by comparison of 
their powder characteristics with those found in the 
literature [24]. Arthrospira is a genus of cyanobacteria 
that constitutes dietary supplements commonly known 
as spirulina. This alga has long been used as food, and 
although most alga are innocuous, a significant 
proportion of cyanobacterial species are harmful due to 
the production of cyanotoxins [25]. The possible 
presence of these toxins in these DS reinforces the need 
for a better-quality control [26]. 
Conclusions 
 From a regulatory perspective, it is necessary to 
develop rapid and sensitive methods for detecting 
adulterants in DS. In this paper we report the presence 
of tadalafil, a drug employed for the treatment of ED, as 
an adulterant in a DS. For the quantification of tadalafil, 
a sensitive and reliable HPLC-MS/MS method was 
developed. This method could be suitable for the 
analysis of DS in various forms, including tablets, 
powders, liquids and pills. The presence of spirulina, 
which was not declared in the label, was also identified 
by microscopic techniques. As DS are considered foods, 
they do not require any safety assessment prior to their 
commercialisation. The methods described for the 
isolation, purification, identification and quantification of 
tadalafil in the DS would be useful for the detection of 
this drug and other related compounds in commercial 
DS formulations.  
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